SYTL2
Basic information
Region (hg38): 11:85694224-85811159
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SYTL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 100 | 112 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 101 | 11 | 5 |
Variants in SYTL2
This is a list of pathogenic ClinVar variants found in the SYTL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-85695241-G-T | not specified | Uncertain significance (Nov 21, 2024) | ||
11-85695256-T-C | not specified | Uncertain significance (Jan 19, 2024) | ||
11-85695273-C-A | not specified | Uncertain significance (Aug 19, 2024) | ||
11-85695275-T-C | not specified | Uncertain significance (May 15, 2024) | ||
11-85696200-C-T | not specified | Uncertain significance (Jan 05, 2022) | ||
11-85696201-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
11-85696204-G-T | not specified | Uncertain significance (Jan 23, 2023) | ||
11-85696222-T-C | not specified | Uncertain significance (Nov 13, 2024) | ||
11-85696356-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
11-85696378-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
11-85698035-C-G | not specified | Uncertain significance (Jan 12, 2024) | ||
11-85698049-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
11-85698061-T-C | not specified | Uncertain significance (Jul 26, 2024) | ||
11-85700518-G-A | not specified | Uncertain significance (Jul 30, 2024) | ||
11-85704862-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
11-85704871-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
11-85704895-T-A | not specified | Uncertain significance (Jun 29, 2023) | ||
11-85704932-C-T | not specified | Uncertain significance (Mar 17, 2023) | ||
11-85704955-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
11-85704956-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
11-85704996-C-G | not specified | Uncertain significance (Jun 17, 2024) | ||
11-85705004-T-C | not specified | Uncertain significance (Aug 12, 2024) | ||
11-85707441-G-A | Likely benign (Nov 01, 2022) | |||
11-85709340-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
11-85709341-G-A | not specified | Uncertain significance (Dec 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SYTL2 | protein_coding | protein_coding | ENST00000354566 | 13 | 116918 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.26e-21 | 0.123 | 125667 | 2 | 78 | 125747 | 0.000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.20 | 725 | 639 | 1.13 | 0.0000305 | 8354 |
Missense in Polyphen | 192 | 172.33 | 1.1142 | 2277 | ||
Synonymous | 0.839 | 216 | 232 | 0.930 | 0.0000115 | 2421 |
Loss of Function | 1.49 | 38 | 49.3 | 0.771 | 0.00000227 | 683 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000272 | 0.000272 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00114 | 0.00103 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000247 | 0.000246 |
Middle Eastern | 0.00114 | 0.00103 |
South Asian | 0.000753 | 0.000752 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform 1 acts as a RAB27A effector protein and plays a role in cytotoxic granule exocytosis in lymphocytes. It is required for cytotoxic granule docking at the immunologic synapse. Isoform 4 binds phosphatidylserine (PS) and phosphatidylinositol- 4,5-bisphosphate (PIP2) and promotes the recruitment of glucagon- containing granules to the cell membrane in pancreatic alpha cells. Binding to PS is inhibited by Ca(2+) while binding to PIP2 is Ca(2+) insensitive. {ECO:0000269|PubMed:17182843, ECO:0000269|PubMed:18266782, ECO:0000269|PubMed:18812475}.;
- Pathway
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer
(Consensus)
Recessive Scores
- pRec
- 0.0897
Intolerance Scores
- loftool
- 0.995
- rvis_EVS
- 1.34
- rvis_percentile_EVS
- 94.23
Haploinsufficiency Scores
- pHI
- 0.216
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.111
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sytl2
- Phenotype
- digestive/alimentary phenotype;
Gene ontology
- Biological process
- intracellular protein transport;exocytosis;vesicle docking involved in exocytosis;negative regulation of phosphatase activity;vesicle-mediated transport;positive regulation of mucus secretion;protein localization to plasma membrane
- Cellular component
- cytoplasm;plasma membrane;membrane;extrinsic component of plasma membrane;melanosome;exocytic vesicle
- Molecular function
- phosphatidylserine binding;protein binding;phosphatidylinositol-4,5-bisphosphate binding;Rab GTPase binding;phosphatase binding;neurexin family protein binding